The NYRACTA brand, founded in 1997 (Ireland), from 1722 sister brands and 17478 competing brands. NYRACTA is owned by GSK PLC, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is GB00BN7SWP63. NYRACTA belongs to the Drug Manufacturers business sector.